Article
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy - 1 Feb 2013
Pang Yu, Lu Jie, Wang Yufeng, Song Yuanyuan, Wang Shengfen, Zhao Yanlin
Abstract excerpt
Rifampin (RIF) susceptibility is a key factor in determining the treatment effectiveness of the standardized treatment regimens. In Mycobacterium tuberculosis, both target gene mutation and the efflux pump play major roles in the resistance to antituberculosis drugs. By eliminating RIF-resistant strains with rpoB mutation, the choice of RIF-monoresistant strains may allow us to identify the RIF-specific efflux...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
